Global Pricing and Product Strategy
Evidence-based positioning and pricing approaches substantiate your value
There Are Essential Market Considerations—Beyond Price—That Factor Into Biosimilar Adoption Rates
This Precision Brief harnesses proprietary research with payers and clinicians from 9 European countries to expose what’s driving customer decisions on anti-TNF biosimilars.
The Precision difference. Providing knowledge born of experience and the ability to adapt to shifting market conditions
Our company is built around medical innovation. We understand the challenges and opportunities created by precise, targeted treatments—and we answer them with precise, targeted solutions. We specifically tailor answers to your needs and your data, then ensure those answers translate effectively in a changing marketplace.
A flexible framework. Responding to an evolving marketplace
Some challenges are effectively met by proven frameworks, while others demand the flexibility to produce results under shifting circumstances. We are known for both.
An evidence-based approach. Developing value-based pricing strategies
Our pricing strategies clearly articulate the clinical evidence that substantiates value to global payers, regulators, and patients.
The insight of former payers. Applying real-world expertise to due diligence
Backed by former payer decision makers from around the globe, our payer advisors capitalize on deep experience to develop your product and pricing strategy.
A seasoned team. Working with experience
Only senior team members lead stakeholder interviews, bringing the skills and experience to probe and challenge effectively.
Integrated message development. Linking your communication strategy to your value proposition
We think of the end from the beginning, so your marketing needs inform your strategy, just as your value proposition informs your communications.
Discover all the ways we can support your product. Download the brochure
Our Approach: A Structured Framework
Value proposition and price
Assess product value and value-based price
- Target positioning options
- Net incremental benefit
Assess the underlying market dynamics that will drive product value
- Evolving disease and payer landscape
- Payer evidence criteria and willingness to pay
- Physician and patient influence
- Competitive forces
Assess product- and market-level trade-offs to optimize pricing and access
- Price-access trade-offs by market/channel
- Cross-market launch sequence
- Indication sequencing